Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Raoul Tibes & Ruben A Mesa. (2013) Emerging drugs for polycythemia vera. Expert Opinion on Emerging Drugs 18:3, pages 393-404.
Read now
Read now
Raoul Tibes, James M Bogenberger & Ruben A Mesa. (2012) Recent developments in myelofibrosis. Blood and Lymphatic Cancer: Targets and Therapy 2, pages 125-136.
Read now
Read now
Raoul Tibes, James M Bogenberger & Ruben A Mesa. (2012) JAK inhibition: the key to treating myeloproliferative neoplasm?. Expert Review of Hematology 5:6, pages 583-585.
Read now
Read now
Raoul Tibes, James M Bogenberger, Holly L Geyer & Ruben A Mesa. (2012) JAK2 inhibitors in the treatment of myeloproliferative neoplasms. Expert Opinion on Investigational Drugs 21:12, pages 1755-1774.
Read now
Read now
Steven Okoli & Claire Harrison. (2011) Emerging treatments for essential thrombocythemia. Journal of Blood Medicine 2, pages 151-159.
Read now
Read now
Articles from other publishers (7)
Stine Ulrik Mikkelsen, Lasse Kjaer, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Christen Bertel Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Vibe Skov & Hans Carl Hasselbalch. (2018) Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis. Cancer Medicine 7:8, pages 3571-3581.
Crossref
Crossref
Raoul Tibes & Ruben A. Mesa. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
816
829
.
Rebecca Sonu, Joo Y Song & Mingyi Chen. (2012) Extramedullary hematopoiesis associated with myeloproliferative neoplasm manifesting as pleural effusion: case report and review of literature. Journal of Hematopathology 5:4, pages 341-347.
Crossref
Crossref
Raoul Tibes, James M. Bogenberger, Kasey L. Benson & Ruben A. Mesa. (2012) Current Outlook on Molecular Pathogenesis and Treatment of Myeloproliferative Neoplasms. Molecular Diagnosis & Therapy 16:5, pages 269-283.
Crossref
Crossref
Raoul Tibes, Gurcharan Singh Khera & Ruben A. Mesa. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
647
658
.
Mamdooh Gari, Fatin Al-Sayes, Farid Ahmed, Abdul Ali Peerzada, Adel Abuzenadah, Lubna S. Mira, Mohammed Al-Qahtani, Ashraf Dallol, Adeel Chaudhary, Mohammed Mahnashi & Ghazi Damanhouri. (2012) JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients. Open Journal of Blood Diseases 02:02, pages 17-21.
Crossref
Crossref
John Anastasi. (2011) The myeloproliferative neoplasms including the eosinophilia-related myeloproliferations associated with tyrosine kinase mutations: changes and issues in classification and diagnosis criteria. Seminars in Diagnostic Pathology 28:4, pages 304-313.
Crossref
Crossref